Clinical Trial Update: Effect of Topical Nepafenac in Macular Thickening Related to Pan-retinal Photocoagulation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating topical nepafenac for macular thickening and edema after pan-retinal photocoagulation was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema

Drugs mentioned

• Nepafenac (nepafenac)

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Macular Thickening, Macular Edema | Phase 2 | Status: TERMINATED